C the Signs Secures $8 Million in Funding

C the Signs Secures $8 Million in Funding

C the Signs, a London, UK-based AI-powered cancer detection platform, has secured $8 million in funding.

The investment comes from Khosla Ventures, a venture capital firm that supports entrepreneurs in AI, sustainability, enterprise, consumer, health, and frontier technologies. With over $15 billion in assets under management (AUM), the firm invests in early- to growth-stage companies, focusing on bold, transformative technologies.

With the new funding, C the Signs aims to accelerate the deployment of its technology in the U.S.

Founded in 2017 by Bhavagaya Bakshi and Miles Payling, C the Signs has developed an AI-powered cancer prediction system that identifies patients at risk of cancer at its earliest and most treatable stage. The company's platform uses patient data from electronic health records, incorporating a wide range of personal and environmental data points beyond basic indicators like age and gender.

Funding Details

Company: C the Signs Limited

Raised: $8.0M

Round: Unknown

Funding Date: January 2025

Investor: Khosla Ventures

Company Website: https://www.cthesigns.com/

Software Category: AI Cancer Detection